OSW - Osteoporosis Screening in Older Women

Product Lines:
Advantage MD.

Eligible Population:
Women 66-75 years of age as of December 31 of the measurement year.

Definition:
The percentage of women 65–75 years of age who received osteoporosis screening tests on or between the member’s 65th birthday and December 31 of the measurement year.

Continuous Enrollment:

  • The measurement year and the year prior to the measurement year.

Best Practice and Measure Tips

  • Ensure members without a diagnosis and who have not been treated for osteoporosis receive bone mineral testing.
  • Educate member about bone health and adopting healthy practices:
    • Maintain a balance diet
    • Engage in weight-bearing exercises
    • Adequate Calcium and Vitamin D Intake
    • Preventing and avoiding falls
    • Review medications that may cause bone loss
    • Review diseases, conditions and medical procedures that may cause bone loss
    • Avoiding smoking and limiting alcohol.

Measure Exclusions

Required Exclusions:

  • Members in hospice or using hospice services anytime during the measurement year.
  • Members who died any time during the measurement year
  • Palliative Care
  • Frailty and Advanced Illness 
  • Living in Long Term Care
  • Members who had a dispensed prescription to treat osteoporosis (Osteoporosis Medications List) any time on or between January 1 three years prior to the measurement year through December 31 of the year prior to the measurement year.
  • Members who had a claim/encounter for osteoporosis therapy (Osteoporosis Medication Therapy; Long-Acting Osteoporosis Medications) any time in the member’s history through December 31 of the year prior to the measurement year.

Osteoporosis Medications

Description Prescription
Bisphosphonates
  • Alendronate 
  • Alendronate-cholecalciferol
  • Ibandronate
  • Risedronate
  • Zoledronic acid
Other agents
  • Abaloparatide 
  • Denosumab
  • Raloxifene
  • Romosozumab
  • Teriparatide

Exclusion Codes

  • Osteoporosis Medication Therapy Value Set
    • HCPCS: J0897, J1740, J3110, J3111, J3489
  • Long-Acting Osteoporosis Medications Value Set
    • HCPCS: J0897, J1740, J3489

Measure Codes

  • Osteoporosis Screening Tests 
    • CPT: 76977, 77078, 77080, 77081, 77085